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Abstract
Background: Familial amyloidotic polyneuropathy (FAP) is a peripheral neuropathy caused by the extracellular
accumulation and deposition of insoluble transthyretin (TTR) aggregates. However the molecular mechanism that
underlies TTR toxicity in peripheral nerves is unclear. Previous studies have suggested that amyloidogenic proteins
can aggregate into oligomers which disrupt intracellular calcium homeostasis by increasing the permeability of the
plasma membrane to extracellular calcium. The aim of the present study was to examine the effect of TTR on
calcium influx in dorsal root ganglion neurons.
Results: Levels of intracellular cytosolic calcium were monitored in dorsal root ganglion (DRG) neurons isolated
from embryonic rats using the calcium-sensitive fluorescent indicator Fluo4. An amyloidogenic mutant form of TTR,
L55P, induced calcium influx into the growth cones of DRG neurons, whereas wild-type TTR had no significant
effect. Atomic force microscopy and dynamic light scattering studies confirmed that the L55P TTR contained
oligomeric species of TTR. The effect of L55P TTR was decreased by blockers of voltage-gated calcium channels
(VGCC), as well as by blockers of Nav1.8 voltage-gated sodium channels and transient receptor potential M8
(TRPM8) channels. siRNA knockdown of TRPM8 channels using three different TRPM8 siRNAs strongly inhibited
calcium influx in DRG growth cones.
Conclusions: These data suggest that activation of TRPM8 channels triggers the activation of Nav1.8 channels
which leads to calcium influx through VGCC. We suggest that TTR-induced calcium influx into DRG neurons may
contribute to the pathophysiology of FAP. Furthermore, we speculate that similar mechanisms may mediate the
toxic effects of other amyloidogenic proteins such as the b-amyloid protein of Alzheimer’s disease.
Background
Protein misfolding is a common feature of many neuro-
degenerative diseases. In some of these diseases, such as
the synucleinopathies and the tauopathies, cytoplasmic
proteins aggregate to form intracellular deposits. How-
ever, in the amyloidoses, which include Alzheimer’sd i s -
ease (AD), prion diseases and the British and Danish
familial dementias, proteinaceous aggregates are
observed extracellularly [1-4]. There is increasing
evidence that the mechanism of neurotoxicity in these
amyloidoses is similar and that it is the conformation of
the aggregated protein, rather than its specific amino
acid sequence which results in altered membrane per-
meability to calcium [5]. Therefore, studies on the
mechanism of neurotoxicity in one disease may provide
insights into the mechanisms involved in other diseases.
Familial amyloidotic polyneuropathy (FAP) is a rare
autosomal dominant disease characterised by the deposi-
tion of transthyretin (TTR) protein in peripheral nerves.
The early clinical manifestations of FAP include pro-
gressively aberrant thermosensation and nociception in
the lower extremities followed by profound autonomic
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tein that has been well characterised for its role in the
transport of thyroxine and retinol [8]. More than 100
TTR mutations are known, and most have been shown
to be amyloidogenic [10]. Many studies have shown that
mutant TTR aggregates to form oligomers more readily
than wild-type TTR, and that further aggregation leads
to the formation of amyloid fibrils [11]. There is a corre-
lation between the rate of aggregation of TTR in vitro
and the extent or severity of the disease phenotype. For
example, the rare L55P mutation produces a more
aggressive amyloidosis than the more common V30M
mutation, and in-vitro studies show that L55P TTR
aggregates more much readily than V30M TTR [12-16].
The mechanism by which TTR forms fibrils is not
entirely understood. Some studies suggest that amyloid
deposition involves the formation of low molecular
weight “nuclei” that must reach a critical concentration
before fibril elongation [17]. However, other studies sug-
gest that amyloid aggregation may be a nucleation-inde-
pendent process [18,19]. More specifically, and
consistent with this latter view, Hammarström et al [20]
and Hurshman Babbes et al [14] have shown that TTR
aggregation may be a nucleation-independent process.
Mutant TTR has been shown to be toxic to cells in cul-
ture [12,21]. It has been reported that TTR-induced
toxicity is mediated by the receptor for advanced glyca-
tion end-products (RAGE) and that activation of RAGE
leads to endoplasmic reticulum stress, activation of
ERK1/2 and caspase-dependent apoptosis [22]. There is
also evidence to suggest that misfolded proteins like
TTR mediate their toxic effects by binding directly to
lipid-rich areas of the plasma membrane [13,23]. Also,
the toxicity of TTR aggregates is correlated with mem-
brane binding affinity, destabilisation of cell membrane
fluidity and subsequent decrease in cell viability [13].
There is ample evidence suggesting that some of the
toxic effects of amyloid proteins are mediated via an
increase in calcium permeability. For example, the b-
amyloid protein (Ab) of AD is known to induce calcium
influx into cells [24,25]. This disruption of calcium
homeostasis is likely to cause abnormal neuronal func-
tion since calcium is an important mediator of synaptic
plasticity and excitotoxicity. However, the mechanism
by which amyloid proteins induce calcium entry in cells
is poorly understood.
Previously, we have shown that in SH-SY5Y neuro-
blastoma cells, TTR induces an influx of extracellular
calcium across the plasma membrane. This TTR-
induced increase in calcium permeability is primarily
mediated by voltage-gated calcium channels (VGCC),
with a small proportion (~20%) of the calcium influx
through voltage-independent channels [12]. However,
neuroblastoma cells are not a physiologically relevant
cell type for studying FAP. FAP is a peripheral poly-
neuropathy involving amyloid deposition affecting per-
ipheral neurons including sensory neurons of dorsal
root ganglia (DRG).
In the present study, we examined the effect of amy-
loidogenic forms of TTR on calcium levels in cultured
DRG neurons. We demonstrate that TTR induces cal-
cium influx into DRG neurons, similar to that observed
using SH-SY5Y cells. Importantly, we demonstrate that
calcium influx into the growth cones of small-diameter
TrkA-positive DRG neurons requires the presence of
Nav1.8 voltage-gated sodium channels and transient
receptor potential (TRP) M8 channels. The results sug-
gest that activation of TRPM8 channels by L55P TTR
results in the subsequent opening of voltage-sensitive
sodium and calcium channels. Our study suggests that
TRP channels may be an important therapeutic target,
not only for the development of drugs for the treatment
of FAP, but also for many important neurodegenerative
diseases.
Results
Effect of TTR on calcium
Previously, we showed that the amyloidogenic TTR pro-
tein variant L55P caused a significant calcium influx
into SH-SY5Y neuroblastoma cells [12]. These findings
led us to examine whether calcium dysregulation was a
feature of L55P-induced toxicity in sensory neurons,
which are a pathophysiologically relevant cell system.
Initially, we examined whether L55P could elicit a cal-
cium response in DRG neurons. DRG growth cones are
highly accessible structures and easily imaged using rou-
tine techniques. They express a variety of receptors and
ion channels, crucial for a variety of autonomous signal-
ling mechanisms involved in motility [26], cytoskeletal
rearrangements [27] and transduction of guidance mole-
cules [28]. Significantly, calcium is a key second messen-
ger molecule involved in the transduction all of these
processes. To examine the effect of TTR on calcium in
DRG, we used single-wavelength calcium imaging with
the cell-permeable calcium indicator Fluo-4 AM and
monitored fluorescence responses after the application
of TTR (0.5 mg/ml) to the incubation medium.
Between 12-24 hr after plating, in the presence of
NGF, DRG cultures contained predominantly small-dia-
meter (<15 μm) neurons with extensive axons and large,
effusive growth cones. Larger diameter neurons which
are typically observed in vivo were less numerous in cul-
ture and typically were devoid of growth cones and
were not imaged. After addition of freshly prepared
L55P to the culture medium, a sustained increase in the
cytosolic calcium concentration ([Ca
2+]i) was observed
in many neurons. [Ca
2+]i was observed to increase initi-
ally in distal growth cones approximately 100 sec after
Gasperini et al. Molecular Neurodegeneration 2011, 6:19
http://www.molecularneurodegeneration.com/content/6/1/19
Page 2 of 12addition of L55P to the culture medium (Figure 1A,
arrows), and then this increase in [Ca
2+]i in growth
cones was followed by a rise in [Ca
2+]i in the cell soma,
approximately 100-200 sec after addition of L55P. No
increase in [Ca
2+]i was observed when WT protein was
added to cultures (Figure 1B and 2B).
A st h er i s ei n[ C a
2+]i was observed initially in the
growth cones, we focussed our attention on the effect
of TTR on growth cone calcium dynamics. A closer
examination of growth cones revealed a distinct spatio-
temporal pattern of calcium fluorescence. Initially, dis-
crete areas of increased calcium were detected at fili-
podial tips and lamellipodial leading edges (Figure 2A,
arrows). Within 300 sec of L55P addition, regions of
increased calcium flux were evident over the entire
growth cone. Addition of freshly prepared V30M pro-
tein had little effect on [Ca
2+]i,( F i g u r e2 C ) .H o w e v e r ,
when V30M was aged for 36 hr, a small calcium influx
was observed (see Additional file 1). These results are
consistent with our previous calcium imaging experi-
ments using SH-SY5Y cells [12] which showed that
aged V30M induced calcium influx and was toxic to
the cells in vitro.
To determine whether the rise in cytoplasmic calcium
originated from extracellular or intracellular sources,
growth cones were exposed to L55P and imaged in cal-
cium and magnesium-free imaging medium containing
300 μM EGTA. This treatment completely abolished the
sustained rise in [Ca
2+]i seen in complete media (Figure
2D). We also examined the effect of depleting endoplas-
mic reticulum (ER) calcium stores on the L55P-induced
increase in [Ca
2+]i by treating cultures with thapsigargin
(150 nM for 30 min) prior to imaging. Thapsigargin did
not significantly reduce the calcium influx (Figure 2D).
Taken together, these data suggest that the increase in
[Ca
2+]i by L55P in DRG originates from extracellular
sources.
Analysis of aggregation state
As L55P induced calcium influx and WT did not, we
examined the aggregation state of the two preparations
used for the calcium imaging studies (Figure 3). Freshly
prepared WT and L55P were first analysed by atomic
force microscopy (AFM) (Figure 3A). Using this method,
both forms of TTR contained predominantly globular or
amorphous particles ranging in apparent size from
approximately 10-50 nm in diameter. No fibrillar struc-
tures were observed. The calculated diameter of a native
TTR tetramer is approximately 7 nm. Therefore, the smal-
lest particles (10 nm) were probably tetramers, as tip con-
volution effects lead to an overestimation of the size of
objects in the XY plane. As a single AFM field did not
reveal dramatic differences in particle size distribution
between the WT and L55P forms of TTR, quantitative
image analysis of AFM particle cross-sectional area was
also performed. This revealed that average apparent parti-
cle sizes of L55P (263 ± 96 nm
2, n = 86) were greater than
those of the WT preparation (162 ± 63 nm
2, n = 52).
To examine the state of aggregation of TTR prepara-
tions further and to obtain a more accurate measure of
particle size distribution, both preparations were also
analysed by dynamic light scattering (DLS) (Figure 3B).
WT showed a discrete peak intensity corresponding to a
diameter of 7.7 nm ± 0.6 nm, whereas L55P showed an
additional peak intensity corresponding to a particle size
of 29.4 nm ± 2.6 nm. Assuming a globular structure and
as p e c i f i cd e n s i t yo f1 . 3 9g / c m
3, which would be typical
for many proteins, this siz ew o u l dc o r r e s p o n dt oa
molecular mass of 1810 ± 160 kDa. This molecular spe-
cies would therefore be predicted to contain approxi-
mately 130 TTR monomers.
Effect of ion channel blockers
As voltage-gated calcium channels (VGCC) were pre-
viously found to mediate calcium entry in SH-SY5Y
cells [12], and as DRG sensory neurons express a variety
of VGCCs [29], we examined whether L55P could
Figure 1 Effect of TTR on calcium. Cultures of DRG neurons were
treated with L55P (A) or wild-type (B) TTR and intracellular calcium
flux (ΔF/F0) was measured over a 500 sec time course. Addition of
L55P elicited greater calcium fluxes than WT. Significantly, calcium
entry at growth cones (arrows) occurred earlier than at DRG cell
soma. Scale bar is 5 μm.
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mechanism at DRG growth cones.
First, we examined the involvement of VGCC in TTR-
induced calcium influx (Figure 4A). The L-type VGCC
blocker nifedipine (5 μM) blocked L55P-induced cal-
cium influx approximately 50%. Although mean levels of
calcium influx were lower in the presence of the P-type
VGCC inhibitor, ω-agatoxin IVA (1 μM) or the N-type
VGCC inhibitor ω-conotoxin GVIA (1 μM), these differ-
ences were not statistically significant. To examine the
possibility that the activation of L-type VGCC by L55P
m i g h tb ed u et oac h a n g ei nm e m b r a n ep o t e n t i a l ,w e
examined the effect of voltage-gated sodium channel
(NaV) blockers. Tetrodotoxin (TTX) (2 μM) did not sig-
nificantly reduce the magnitude of L55P-induced cal-
cium influx. However, the lack of effect of TTX was not
unexpected since TTX-resistant (TTXR)N a V channels
(NaV1.8) predominate in DRG neurons [30,31]. There-
fore, we also used two relatively specific inhibitors of
TTXR channels, ambroxol (5 μM) and carbamazepine (5
μM). Blockade of NaV1.8 channels significantly reduced
TTR-induced calcium influx by 67% and 74%,
Figure 2 Dynamics of extracellular calcium influx. (A) Single wavelength calcium imaging of isolated DRG growth cones revealed distinct
spatio-temporal kinetics of calcium flux (ΔF/F0), in growth cones. Calcium signals were not homogeneous in the central area and extended out
to filipodial tips and lamelipodial leading edges (arrows). (B) Example of growth cone calcium responses to L55P treatment compared to WT
protein added to imaging buffer (arrow) (C-D) Pooled results of calcium fluorescence after TTR addition (arrow). L55P (0.5 mg/ml, n = 18) elicited
a sustained increase in fluorescence when compared with WT (0.5 mg/ml, n = 15) (B), fresh and V30M (0.5 mg/ml, n = 16). (D) L55P calcium
influx in DRG growth cones was derived from extracellular sources. L55P addition did not elicit a significant calcium increase when cells were
imaged in calcium-free buffer (n = 8). Significant L55P-induced calcium influx was seen in growth cones following treatment with thapsigargin
(150 nM) to deplete calcium stores (n = 12). Scale bar is 5 μm. Error bars indicate mean ± SEM.
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channels was necessary for L55P-induced calcium influx.
Since blockade of voltage-gated channels failed to
completely block calcium entry, we explored the possibi-
lity that the remaining calcium influx was mediated by
voltage-insensitive channels. The transient receptor
potential (TRP) cation channels are important mediators
of sensory stimuli in the peripheral nervous system [32].
To determine the involvement of TRP channels in
growth cone calcium entry following treatment with
TTR, we used a range of TRP channel blockers with
various specificities for inhibiting specific classes of TRP
channels. In support of the view that TRP channels
mediate TTR-induced calcium entry, we found that
SKF96365 (5 μM), an inhibitor of TRPC [33] and
TRPM8 channels [34], strongly blocked L55P-induced
calcium entry in DRG growth cones. Interestingly, 5 μM
BCTC, an antagonist of TRPV1 and TRPM8 channels
[35] also decreased the L55P-induced calcium influx in
growth cones from small-diameter DRG neurons.
These results raised the possibility that a TTR-induced
influx of cations through TRPM8 channels may lead to
a membrane depolarization that is sufficient to activate
Figure 3 Analysis of TTR aggregation by AFM and dynamic
light scattering. (A) Freshly prepared WT and L55P were examined
using AFM. Representative AFM images show a relatively
homogeneous dispersion of non-fibrillar particles in both WT and
L55P preparations. Image analysis of particle cross-sectional area
revealed a distribution of significantly larger L55P particle sizes
(arrows) compared with those of freshly prepared WT protein (WT
TTR 162 ± 63 nm
2 compared with L55P TTR 263 ± 96 nm
2, n = 86).
Freshly prepared TTR protein was also examined using dynamic
light scattering. (B) Protein samples were measured repetitively
(replicates analyses in grey, mean of replicates in heavy black line)
in a DLS every 30 min over a 4-6 hr time period by DLS. In addition
to the native tetrameric molecule (7.66 ± 0.56 nm) corresponding to
an estimated MW of 78 ± 5.7 kDa, a significant oligomeric species
(29.38 ± 2.59 nm) corresponding to an estimated MW of 1810 ±
159.8 kDa, was detected in L55P samples compared to WT samples.
Large molecular mass aggregates (>1000 nm in diameter) were not
detected in protein preparations during the 4-6 hr analysis period.
Scale bar is 100 nm.
Figure 4 Effect of ion channel blockers on L55P TTR-induced
calcium influx and analysis of sensitivity to icilin and capsaicin,
(A) L55P was applied to DRG growth cones in the presence of
VGCC inhibitors (nifedipine, ω-agatoxin IVA, ω-conotoxin GIVA), NaV
inhibitors (tetrodotoxin, ambroxol and carbamazepine) and TRP
inhibitors (SKF-96365, BCTC). The resulting maximal calcium influx
(max ΔF/F0) calculated over the imaging period (7 min) was
calculated. (B) Effect of capsaicin (1 μM) and icilin (100 μM) on
cytosolic calcium in DRG growth cones in culture. When DRG
cultures were pre-treated with ambroxol (5 μM), icilin-induced
calcium fluorescence was significantly decreased. All graphs show
maximal ΔF/F0 ± SEM for n = 12-24 growth cones. Significant
differences from control values are depicted as: * p < 0.05; **p <
0.005; Mann-Whitney U-test. Error bars indicate mean ± SEM.
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subsequent opening of VGCCs. To test this idea, we
examined the effect of the TRPM8 agonist icilin (100
μM) on calcium influx. Icilin treatment caused a similar
increase in [Ca
2+]i to that of L55P (Figure 4B), suggest-
ing that the majority of cultured neurons were TRPM8
positive. In contrast, the vanilloid receptor (TRPV) ago-
nist capsaicin (1 μM) resulted in a significantly
decreased response in growth cone [Ca
2+]i.W h e nD R G
neuron cultures were pretreated with ambroxol (5 μM)
for 10 min, the icilin-induced increase in [Ca
2+]i was
also significantly attenuated( F i g u r e4 B ) .T h ep r e s e n c e
of TRPM8 channels was confirmed by immunocyto-
chemical staining (Figure 5B and 5D), which demon-
strated that the majority (56%) of small-diameter
neurons (i.e. neurons with a nuclear diameter <15 μm)
in the culture were TRPM8 positive, and a similar per-
centage (48%) were TrkA positive (Figure 5A and 5C).
Since previous studies have shown that TRPM8-positive
neurons in vivo almost exclusively express TrkA [31],
and our DRG culture medium contained NGF, which
enhances cell survival and stimulates neurite outgrowth
via a TrkA-dependent mechanism [36], it was not sur-
prising that most of the surviving small diameter neu-
rons with growth cones were TRPM8 positive (Figure
5E). Taken together, these results demonstrate that
although TRPM8 channels are found only on a relatively
small (13-20%) population of DRG neurons in vivo [31],
they are a major TRP channel on DRG neurons cultured
in the presence of NGF. Significantly, the possibility that
TRPM8 conductance was sufficient to activate NaV1.8
channels was confirmed by the inhibition of the icilin-
induced calcium entry in small diameter DRG neuron
growth cones by a NaV1.8 antagonist, ambroxol.
siRNA silencing of TRPM8
To confirm the involvement of TRPM8 channels in
L55P-induced calcium entry, we used a siRNA knock-
down strategy in combination with calcium imaging of
DRG growth cones. DRG neurons were loaded with
fluorescently (Cy3) tagged siRNA to identify those cells
that had taken up the oligonucleotide. Immunostaining
of control siRNA loaded DRG growth cones with a
polyclonal anti-TRPM8 antibody revealed extensive, but
non-homogeneous punctate staining throughout DRG
growth cones, extending from the central area to distal
filopodial tips (Figure 6A). In neurons loaded with a
specific TRPM8 siRNA (#57381), there was significant
knockdown of TRPM8 expression, especially in filipodial
tips, lamellipodia and transitional zone of growth cones
(Figure 6A,B). The specificity of knockdown was con-
firmed by western immunoblot analysis of DRG primary
cultures loaded with control and specific TRPM8 siRNA
oligonucleotides (Figure 6C,D). Proteins in DRG
cultures were separated by SDS-PAGE, transferred to a
PVDF membrane and probed with a polyclonal anti-
TRPM8 antibody. A band of immunoreactive protein
migrated at a molecular mass of 135 kDa, consistent
with the predicted size of TRPM8 (Figure 6C). The
staining intensity of the TRPM8 band was significantly
reduced in cells loaded with TRPM8 siRNA oligonucleo-
tides, when compared with cells treated with a control
oligonucleotide (Figure 6D).
Figure 5 TrkA- and TRPM8 expression and morphology of DRG
neurons in culture. (A&B) Small diameter DRG neurons in culture
express the TrkA receptor and TRPM8 channels. Immunofluoresence
images of 12 hr DRG cultures stained with (A) an anti-TrkA (green),
(B) an anti-TRPM8 (green) antibodies, and DAPI (blue). Analysis of
somatic diameters displaying immunoreactivity (closed circles) for
(C) TrkA and (D) TRPM8 show a significant bias of TrkA and TRPM8
immunoreactivity (closed circles) in smaller neurons (<15 μm)
compared with TrkA and TRPM8 negative neurons (open circles). (n
= 326 and 223 cells counted respectively, scale bar is 20 μm). (E)
TRPM8 immunoreactivity in culture. DRG neurons displaying effusive
growth cone morphologies (suitable of calcium imaging
experiments) were TRPM8 positive (scale bar is 50 μm).
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L55P-induced calcium influx, DRG neurons were treated
with each of three separate TRPM8 siRNA oligonucleo-
tides and then examined for L55P-induced calcium
entry using calcium imaging (Figure 7A,B). Significantly,
there was almost complete abolition of the calcium
influx effect in the TRPM8 siRNA treated neurons,
whereas neurons treated with a non-specific control
siRNA responded to the TTR treatment with an
increase in [Ca
2+]i (Figure 7C,D). The data from the
pharmacological studies and from the siRNA studies,
when taken together, clearly demonstrated that TRPM8
channels are required for L55P-induced calcium entry in
DRG growth cones.
Discussion
In this study we report that the mutant TTR variant
L55P, induces calcium influx in growth cones of DRG
sensory neurons. The extracellular calcium influx seen
in DRG growth cones occurred within minutes of expo-
sure to L55P and was sustained for at least 500 sec. The
observation that L55P-mediated increases in growth
cone calcium originated exclusively from extracellular
sources confirms previous work in SH-SY5Y cells that
showed TTR-induced calcium influx is mediated pri-
marily by ion channels at the plasma membrane [12]. In
FAP, deposition of aggregated TTR protein is a patholo-
gical hallmark of a polyneuropathy and subsequent per-
ipheral neurodegeneration. These results strongly
suggest that in FAP, distal sensory neurons are exposed
to prolonged calcium dysregulation, leading to progres-
sively aberrant signalling in small-diameter sensory
neurons.
Our data show that a significant portion of the cal-
cium influx was due to the opening of VGCCs. For
example, approximately 50% of the calcium influx was
blocked by the L-type channel blocker nifedipine. We
Figure 6 siRNA silencing of TRPM8 expression. Figure shows the
level of TRPM8 immunoreactivity as determined by
immunocytochemistry and by western blotting after treatment with
siRNA oligonucleotides. (A) TRPM8 staining of a DRG growth cone
treated with a non-specific control siRNA or with a specific TRPM8
siRNA oligonucleotide (#57381). The dotted line describes outline of
the growth cone in the TRPM8 siRNA culture. (B) Quantitative
analysis of TRPM8 immunocytochemistry shows that there was a
significant decrease in TRPM8 expression in the presence of the
TRPM8 siRNA (#57381, n = 73 growth cones) compared with the
non-specific control siRNA (n = 56 growth cones). (C,D) Western
blot and quantitation of TRPM8 immunoreactivity after treatment
with 3 different TRPM8 siRNA oligonucleotides and a non-specific
control siRNA. (C) Extracts from siRNA-treated DRG cultures were
applied to SDS gels and probed with an anti-TRPM8 antibody. (D)
Quantitative analysis of blots revealed significant knockdown of
TRPM8 protein expression compared to cultures treated with a non-
specific control siRNA. TRPM8 siRNA levels were normalised to
GAPDH expression. Figure shows 60-70% knockdown achieved with
3 separate TRPM8 oligonucleotides. Values are means of 9 replicate
immunoblot lanes over 3 separate experiments. Significant
differences from control are depicted as: ** p < 0.005 as determined
by a Mann-Whitney U-test. Error bars show means ± SEM.
Figure 7 Effect of TRPM8 knockdown on TTR-induced calcium
influx. TRPM8 channels are necessary for L55P-induced calcium
influx. Representative images of DRG neurons loaded with (A) non-
specific control siRNA elicited a greater L55P-induced calcium influx
(ΔF/F0) than growth cones loaded with (B) specific TRPM8 siRNA
(#57381). (C) Pooled results show calcium influx (ΔF/F0) in response
to L55P for control siRNA (closed circles, n = 12) and a specific
TRPM8 siRNA (open circles, n = 16) from 3 separate experiments. (D)
Using 3 different TRPM8 siRNA oligonucleotides results in a similar
reduction in L55P-mediated calcium entry. Significant differences
from control are depicted as: *p < 0.05; **p < 0.005; Mann-Whitney
U-test. Error bars indicate mean ± SEM. Scale bar is 5 μm.
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ity was responsible for the opening of VGCCs. To
answer this question, we examined the effect of voltage-
gated sodium channel blockers on TTR-induced calcium
influx. Nociceptive sensory neurons express a subset of
Nav channels that are resistant to TTX blockade
[30,37-40]. Nav1.8 channels in DRGs are activated by
protein kinase A (PKA) and protein kinase C (PKC)
dependent mechanisms and they are involved in dia-
betes-induced hyperalgesia and allodynia where they
exhibit significantly increased slow and fast ramp activa-
tion profiles and left-shifted voltage-dependent activa-
tion [41,42]. Consistent with the possibility that voltage-
gated sodium channels mediate the TTR-induced open-
ing of VGCC, we found that while TTX had no signifi-
cant effect on calcium influx, ambroxol and
carbamazepine, blockers of TTXR Nav1.8 channels
[43,44], inhibited up to 80% of the calcium influx. As a
small percentage of the calcium influx was not inhibited
by ambroxol or carbamazepine, this suggested that some
influx may have occurred via a voltage-insensitive
mechanism. This latter possibility was supported by the
finding that SKF96365, a relatively non-specific inhibitor
of many types of TRP channels (including TRPM8 chan-
nels) [33,34], and BCTC, an inhibitor of TRPM8 and
TRPV1 channels [35] significantly inhibited calcium
influx. The involvement of TRPM8 channels in TTR-
induced calcium influx was confirmed by experiments
which showed that the TRPM8 agonist icilin induced
similar calcium influx in DRG growth cones and that
the effect of TTR was strongly inhibited by three differ-
ent TRPM8 siRNA oligonucleotides. As TRPM8 chan-
nels are permeable to both sodium and calcium [45,46],
it seems likely that they are both directly responsible for
some of the calcium influx, but they may also contribute
to the changes in membrane potential which trigger
opening of voltage-gated sodium and calcium channels.
It was surprising to observe that TRPM8 channels
were responsible for calcium influx in most growth
cones. Previous studies have shown that TRPM8-posi-
tive cells account for only a small fraction of the total
population of neurons in DRG tissue [45,46]. However,
in our DRG cultures, TRPM8-positive cells accounted
for >50% of all neurons. The greater percentage of
TRPM8-positive cells in the cultures compared with the
number in vivo i sl i k e l yt ob ed u et ot h ep o s i t i v es e l e c -
tion of TrkA-positive small diameter neurons since the
cells were cultured in the presence of NGF.
TRPM8 channels have been described as the prototy-
pic thermosensitive ion channel [45,46]. They are acti-
vated by the compounds menthol, icilin and mild cold
stimuli and are a prominent receptor subtype on small
diameter (C and Aδ fibre) DRG neurons [47]. While
FAP exhibits a variety of clinical manifestations, one of
the most common symptoms is a progressive parasthe-
sia involving the extremities, especially the lower limbs
and affecting thermosensation and nociception
[6,7,48-50]. While the current study strongly suggests
that TRPM8 and Nav1.8 channel activation occurs in
response to L55P attack on DRG neurons in vitro,t h e
involvement of other ion channels in TTR toxicity can-
not be excluded. However, it is likely the parasthesia
seen in FAP is a clinical correlate of a small diameter
sensory neuron phenotype undergoing chronic excito-
toxic insult.
The precise TTR species that mediate the effect on
calcium influx are yet to be elucidated. Preparations of
L55P contained significant amounts of oligomeric aggre-
gates (~1800 kDa) that were not seen in preparations of
wild-type TTR. Urea-denaturation studies suggest that
unlike WT TTR, L55P aggregates through a complicated
pathway involving the formation of dimers and trimers.
However the precise mechanism responsible for the for-
mation of soluble oligomers at physiological pH has yet
to be determined [14]. Soluble oligomeric TTR aggre-
gates are more toxic to cells than fibrillar or monomeric
s p e c i e s[ 1 2 , 1 6 ] .W eh a v ep r e v i o u s l ys h o w nt h a tt h e
aggregation state of TTR variants is correlated with the
magnitude of calcium entry and cytotoxicity in SH-
SY5Y cells [12]. In the present study, freshly prepared
L55P elicited a greater calcium influx in DRG growth
c o n e st h a ne i t h e rV 3 0 Mo rW Tp r o t e i n s .R e i x a c het al.
[51] have reported that while monomers and small oli-
gomeric (<100 kDa) forms of the V30M variant induced
cell death in a human neuroblastoma cell line, the for-
mation of these smaller species proceeded at a relatively
slow rate under physiological conditions.
It remains unclear how aggregated TTR can activate
TRPM8 channels. One possibility is that TTR binds
directly to the channels and causes a conformational
change which leads to channel opening. However, there is
no direct evidence for this. Another possibility is that TTR
binds to a membrane component which triggers the open-
ing of TRPM8 channels. This membrane component
could be a lipid. TTR binds preferentially to phospholipids
in cholesterol-rich regions of membranes and alters the
membrane fluidity [13]. There is some evidence of prefer-
ential localisation of TRPM8 activity at detergent-insoluble
areas of the plasma membrane or lipid rafts [52,53]. As
TRPM8 channels are mechanosensitive [54-58], it is possi-
ble that disruption of the lipid membrane by TTR could
contribute to channel opening. Also, like other TRPM
family members, TRPM8 is activated by a major phospho-
lipid component of lipid rafts, phosphatidylinositol 4,5-
bisphosphate (PIP2) [59-61]. It is likely, therefore, that
L55P-mediated calcium influx at the cell membrane is the
culmination of multiple interactions and further work will
be required to fully explore this possibility.
Gasperini et al. Molecular Neurodegeneration 2011, 6:19
http://www.molecularneurodegeneration.com/content/6/1/19
Page 8 of 12The present study identifies TRPM8 channels as a pos-
sible molecular target for pharmacological intervention
in FAP. Currently, liver transplantation is an effective
treatment for FAP, and several pharmacological interven-
tions such as clonazepam, doxepine and significantly,
carbamazepine, have been shown to be effective in the
symptomatic treatment of the polyneuropathy and para-
sthesia associated with FAP [48]. Recently, small mole-
cule stabilisers which inhibit the aggregation of TTR
have been undergoing promising clinical trials [20].
As amyloidoses may share common mechanisms of
neurotoxicity, this study has implications for understand-
ing the cause of other neurodegenerative diseases. Neu-
ronal calcium dysregulation has also been implicated in
the pathogenesis of a variety of amyloidoses, including
AD [62,63]. Accumulation of aggregated Ab in the AD
brain has been reported to disrupt calcium metabolism
with concomitant downstream cytotoxic effects such as
mitochondrial dysfunction, activation of caspases [64,65]
microtubule destabilisation and tau phosphorylation [66].
While there is some evidence implicating TRP channels
in the pathogenesis of AD [67], it is unclear whether
aggregated Ab interacts directly with TRP channels in
the AD brain and therefore future experiments in this
area would add considerably to our understanding of the
early neurotoxic events in AD.
Conclusions
In this study, we examined the mechanism of TTR-
induced calcium influx in sensory neuron growth cones.
We show that an amyloidogenic form of TTR, L55P, eli-
cited an extracellular calcium influx in a process
mediated by TRPM8 and Nav1.8 channels. Our findings
suggest a molecular correlate of FAP pathogenesis invol-
ving calcium dysregulation at the cell membrane caused
by aggregated or misfolded TTR proteins.
Methods
Materials
Wild-type (WT), V30M and L55P transthyretin were
expressed in BL21(DE3)- RIG CodonPlus E.coli and puri-
fied as described previously [13]. Proteins were incubated
for2-4 hr at 22-24°C prior to their use in calcium imaging
experiments. Pharmacological compounds used in
experiments were obtained from the following sources:
nifedipine, ω-agatoxin IVA, ω-conotoxin GIVA (Alo-
mone Labs, Israel), SKF-96365 (Tocris, Bristol, UK), [N-
(4-tert-butylphenyl)-4-(3-chloropyridin-2-yl)piperazine-
1 - c a r b o x a m i d e ]( B C T C ) ,( E N Z O ,N Y ,U S A ) ,a m b r o x o l
and carbamazepine (Sigma-Aldrich, MO, USA).
Cell culture
All animal experimentation was performed in accor-
dance with the guidelines and protocols of the Animal
Ethics Committee, University of Tasmania. Dissected
thoracic dorsal root ganglia from embryonic day 16-18
(E16-18) hooded Wistar rats were mechanically disso-
ciated into sensory neuron medium (SNM) composed of
Dulbecco’s modified Eagle’sm e d i u m / H a m ’sF - 1 2m e d -
ium 1:1, (Sigma-Aldrich, MO, USA) containing foetal
bovine serum (5% v/v), penicillin G (100 U/ml), strepto-
mycin (100 μg/ml), nerve growth factor (NGF, 50 ng/ml,
Sigma-Aldrich, MO, USA) and N2 neural medium sup-
plement (Invitrogen, CA, USA). Cells were plated onto
poly-ornithine (100 μg/ml, Sigma, MO, USA) and lami-
nin (50 μg/ml, Invitrogen, CA, USA) coated glass
coverslips.
Calcium imaging
Between 12 and 24 hr after plating, sensory neurons,
grown on coverslips, were loaded with Fluo-4 AM cal-
cium indicator (1 μM, Invitrogen, CA, USA) in Hanks
balanced salt solution (HBSS) without phenol red
(Sigma-Aldrich, MO, USA) for 7 min, rinsed with fresh
HBSS and incubated for a further 15 min at 37°C to
allow complete de-esterification. All imaging experi-
ments were carried out at 24-26°C. Calcium-free experi-
ments were performed in calcium-free HBSS (Sigma-
Aldrich, MO, USA) supplemented with 300 μME G T A
(glycol-bis(2-aminoethylether)-N,N,N’,N’-tetra-acetic
acid). Growth cones from small neurons (<15 μm in dia-
meter) were selected for analysis. Freshly prepared TTR
proteins were added to culture dishes to a final concen-
tration of 0.5 mg/ml for all experiments and remained
in contact with growth cones for the duration of the
imaging period. Calcium experiments on aged (36 hr)
protein were only performed using the V30M variant.
Fluorescence images were acquired at 1-5 Hz using a
confocal microscope (Zeiss LSM 510, Jena, Germany)
using a 20× (1.0 NA) water immersion objective. Fluor-
escence images and pixel intensities were analysed using
ImageJ software [68] and custom software (Matlab,
MathWorks, MA, USA). ΔF for each image frame was
calculated by subtracting integrated pixel intensity of a
region of interest encompassing the entire growth cone
from the average integrated pixel intensity or F0,o ft h e
first 20-30 frames of the imaging session for each cell.
Maximal ΔF/F0 was calculated for each growth cone
over the entire 7 min imaging period. Prism 4 (Graph-
Pad Software, CA, USA) and Adobe Illustrator CS3
(Adobe Systems, CA, USA) were used for graphical and
statistical analysis of data.
Atomic force microscopy (AFM)
AFM was performed as previously described [12].
Briefly, TTR solutions (5-50 μg/mL), were deposited on
a surface of freshly cleaved, highly oriented pyrolytic
graphite and incubated at 37°C for 30 min. AFM
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Page 9 of 12analysis was performed on a Digital Instruments Nano-
Scope IV, multimode scanning probe microscope
equipped with a 15 μm E scanner (Veeco Instruments,
NY, USA). Images were obtained in tapping mode at
oscillation frequencies of 200-300 kHz and analyzed
using WSxM 4.0 software (Nanotec Electronica S.L.,
Madrid, Spain).
Analysis of TTR aggregation by dynamic light scattering
(DLS)
Aggregation of wild-type (WT) and L55P TTR (1 mg/
mL in 20 mM phosphate buffer (pH 7.4) containing 150
mM NaCl) was measured at 37°C for 6 hr using DLS.
Measurements at 30 min intervals were acquired on a
Zetasizer Nano S (Malvern Instruments, UK), and ana-
lyzed using Zetasizer Nano software 5.0.2. The hydrody-
namic diameter and predicted molecular masses of
protein species were calculated using Zetasizer Nano
software 5.0.2, utilising the Stokes-Einstein equation and
the Perrin factor to derive an estimate of molecular
mass for a globular protein [69].
siRNA knockdown of TRPM8 expression
Fluorescently (Cy-3) labelled TRPM8 siRNA (GGCCAUG
GAGAGCAUAUGC), (CGAGAAUGCGUCUUCUUUA),
(GCACAAAAAUGUAUGGAAA) and negative control
siRNA oligonucleotides were obtained from (Applied Bio-
systems, CA, USA). Oligonucleotides were loaded into
sensory neurons using previously established methods
[ 7 0 - 7 2 ] .B r i e f l y ,o l i g o n u c l eotides (5 nM) were added to
dissected DRGs in SNM. DRGs were then gently triturated
and maintained in SNM (with 5 nM oligonucleotide)
throughout the culture period (24 hr). Incorporation of
fluorescently labelled oligonucleotides was confirmed by
confocal microscopy (data not shown).
Immunocytochemistry
DRG cultures were fixed in 4% (w/v) paraformaldehyde
and blocked with 10% (v/v) goat serum for 4 hr at 4°C.
The primary antibodies, a polyclonal rabbit anti-TRPM8
(extracellular) (1:1000, Alomone Labs, Israel) or polyclonal
rabbit anti-TrkA (1:1000, Abcam, Cambridge, UK) were
added to coverslips and incubated for 4 hr at 22°C. Detec-
tion of primary antibodies was performed using fluores-
cently labelled goat anti-rabbit antibodies (Invitrogen, CA,
USA). Nuclear staining was performed with 4’,6-diami-
dino-2-phenylindole (DAPI) (Invitrogen, CA, USA).
Images were acquired on a Zeiss LSM 510 confocal micro-
scope and processed using ImageJ, Adobe Photoshop CS3
and Adobe Illustrator CS3 (Adobe Systems, CA, USA).
Immunoblotting
Primary DRG cultures treated with either control or
specific TRPM8 siRNA oligo (5 nM) were established at
high density in 6-well polystyrene culture plates (BD
Falcon, NSW, Australia). Following incubation for 24 hr,
cells were rinsed 3 times in ice-cold PBS. Ice-cold cell
lysis buffer (50 mM Tris-HCl pH 7.4, 150 mM NaCl, 1
m ME D T A ,1 % ,v / v ,T r i t o nX - 1 0 0 ,1 % ,w / v ,N ad e o x y -
cholate, 0.1%, w/v, SDS) supplemented with Complete
®
Mini protease inhibitor cocktail (Roche Diagnostics,
NSW, Australia) was added to dishes and slowly agitated
for 15 min at 4°C. Cell lysates (10 μg total protein) were
separated on 8% SDS-PAGE, transferred onto PVDF
membranes and then blocked overnight in blocking
solution [5% (w/v), non-fat skim milk in 20 mM Tris-
HCl and 150 mM NaCl (TBS)]. Primary antibodies, a
rabbit anti-TRPM8 (1:200 in blocking solution, Alomone
Labs, Israel) and mouse anti-GAPDH (1:2000 in block-
ing solution, Sigma-Aldrich, MO, USA) were added to
the membrane, incubated overnight at 4°C then rinsed
thoroughly in TBS. Membranes were subsequently
probed with goat anti-mouse-HRP or goat anti-rabbit-
HRP secondary antibodies for 1 hr at room temperature.
Conjugates were detected using Immobilon chemilumi-
nescent substrate reagent (Millipore, MA, USA) and a
Chemi-Smart 5000 CCD image acquisition system (Vil-
ber Lourmat, Marne-la-Vallee, France). CCD image ana-
lysis was performed with ImageJ software and statistical
analysis was performed with Prism 4 (GraphPad Soft-
ware, CA, USA).
Additional material
Additional file 1: Comparison of aged and fresh V30M protein on
DRG calcium influx. V30M protein was aged for 36 hr at 24°C then
added to DRG cultures (0.5 mg/ml) in the calcium imaging assay as
described (n = 4). Aged V30M elicited a smaller calcium influx than
freshly prepared L55P protein, but a greater calcium influx than freshly
prepared V30M protein.
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